Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel in Total Knee Arthroplasty
NCT02765815Phase 4Withdrawn
- Sponsor
- Holy Cross Health
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Holy Cross Health. Planned start Feb 2016; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02765815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765815.